NYU Langone Health has been awarded a nearly $70 million, seven-year renewal grant from the National Institutes of Health (NIH) to fund its Clinical and Translational Science Institute (CTSI). The award is the highest level of funding available nationally under NIH’s Clinical and Translational Science Awards (CTSA) Program.

“This award positions NYU Langone at the forefront of translational science,” said Miriam A. Bredella, MD, MBA, director of the CTSI, Bernard and Irene Schwartz Professor of Radiology, and associate dean for translational science. “Through the CTSI, we are building the infrastructure to move discoveries into real-world patient care faster and at scale.”

The CTSI provides scientists and clinicians with biostatistics support, large-scale patient data infrastructure, clinical trial networks, and career development programs. These resources would be prohibitively expensive for any single department to build independently. Since its founding in 2009, the institute has supported nearly 5,000 requests, more than half led by early-career investigators, underscoring the CTSI’s role as a pipeline for developing the next generation of translational scientists. The projects have generated more than 1,500 grants and more than 1,500 peer-reviewed publications contributing to advances in patient care, public health, and health policy.

With the renewal, NYU Langone will expand this work over the next seven years through five priorities: deepening community-engaged research, broadening access to health informatics tools, training the full spectrum of the research workforce, forging regional and national collaborations, and accelerating clinical trial start-up and completion.

NYU Langone's large network, including the Family Health Centers, NYC Health + Hospitals, and all 11 schools and colleges of New York University, enables the CTSI to engage a uniquely wide-ranging urban population, positioning New York City as a living laboratory for translational research.

“Translational research is central to our mission at NYU Langone,” said Dafna Bar-Sagi, PhD, chief scientific officer and executive vice president and vice dean for science. “The CTSI is a critical institutional engine that allows us to turn scientific discovery into better care for patients across New York City and beyond. This award reflects both the strength of our research enterprise and our commitment to ensuring that innovation reaches patients quickly, equitably, and at scale.”

About NYU Langone Health

NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone No. 1 out of 118 comprehensive academic medical centers across the nation for four years in a row, and U.S. News & World Report recently ranked four of its clinical specialties No. 1 in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across seven inpatient locations, its Perlmutter Cancer Center, and more than 320 outpatient locations in the New York area and Florida. The system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise.

Media Inquiries

Greg Williams
Phone: 212-404-3500
Gregory.Williams@NYULangone.org